• Fri. Dec 8th, 2023

Recap: Immunogen Q2 Earnings – Benzinga

ByBenzinga Insights

Jul 29, 2022
Recap: Immunogen Q2 Earnings - Benzinga


Immunogen IMGN reported its Q2 earnings results on Friday, July 29, 2022 at 06:30 AM.

Here’s what investors need to know about the announcement.


Immunogen missed estimated earnings by 14.29%, reporting an EPS of $-0.24 versus an estimate of $-0.21.

Revenue was down $2.79 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 4.54% drop in the share price the next day.

Here’s a look at Immunogen’s past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.21 -1.71 -0.18 -0.18
EPS Actual -0.10 -0.17 -0.18 -0.15
Revenue Estimate 21.47M 25.65M 19.03M 18.92M
Revenue Actual 38.08M 27.99M 9.21M 16.95M

To track all earnings releases for Immunogen visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Image and article originally from www.benzinga.com. Read the original article here.